Influence of Distribution of Animals between Dose Groups on Estimated Benchmark Dose and Animal Distress for Quantal Responses
Author
Abstract
Suggested Citation
DOI: 10.1111/risa.12741
Download full text from publisher
References listed on IDEAS
- Kristi Kuljus & Dietrich Von Rosen & Salomon Sand & Katarina Victorin, 2006. "Comparing Experimental Designs for Benchmark Dose Calculations for Continuous Endpoints," Risk Analysis, John Wiley & Sons, vol. 26(4), pages 1031-1043, August.
- Robert J. Kavlock & Judith E. Schmid & R. Woodrow Setzer, 1996. "A Simulation Study of the Influence of Study Design on the Estimation of Benchmark Doses for Developmental Toxicity," Risk Analysis, John Wiley & Sons, vol. 16(3), pages 399-410, June.
- Christel Faes & Marc Aerts & Helena Geys & Geert Molenberghs, 2007. "Model Averaging Using Fractional Polynomials to Estimate a Safe Level of Exposure," Risk Analysis, John Wiley & Sons, vol. 27(1), pages 111-123, February.
- Carole A. Kimmel & David W. Gaylor, 1988. "Issues in Qualitative and Quantitative Risk Analysis for Developmental Toxicology," Risk Analysis, John Wiley & Sons, vol. 8(1), pages 15-20, March.
- Matthew W. Wheeler & A. John Bailer, 2007. "Properties of Model‐Averaged BMDLs: A Study of Model Averaging in Dichotomous Response Risk Estimation," Risk Analysis, John Wiley & Sons, vol. 27(3), pages 659-670, June.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Joakim Ringblom & Fereshteh Kalantari & Gunnar Johanson & Mattias Öberg, 2018. "Influence of Distribution of Animals between Dose Groups on Estimated Benchmark Dose and Animal Welfare for Continuous Effects," Risk Analysis, John Wiley & Sons, vol. 38(6), pages 1143-1153, June.
- Signe M. Jensen & Felix M. Kluxen & Christian Ritz, 2019. "A Review of Recent Advances in Benchmark Dose Methodology," Risk Analysis, John Wiley & Sons, vol. 39(10), pages 2295-2315, October.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Walter W. Piegorsch & Hui Xiong & Rabi N. Bhattacharya & Lizhen Lin, 2014. "Benchmark Dose Analysis via Nonparametric Regression Modeling," Risk Analysis, John Wiley & Sons, vol. 34(1), pages 135-151, January.
- Joakim Ringblom & Fereshteh Kalantari & Gunnar Johanson & Mattias Öberg, 2018. "Influence of Distribution of Animals between Dose Groups on Estimated Benchmark Dose and Animal Welfare for Continuous Effects," Risk Analysis, John Wiley & Sons, vol. 38(6), pages 1143-1153, June.
- Steven B. Kim & Ralph L. Kodell & Hojin Moon, 2014. "A Diversity Index for Model Space Selection in the Estimation of Benchmark and Infectious Doses via Model Averaging," Risk Analysis, John Wiley & Sons, vol. 34(3), pages 453-464, March.
- Signe M. Jensen & Felix M. Kluxen & Christian Ritz, 2019. "A Review of Recent Advances in Benchmark Dose Methodology," Risk Analysis, John Wiley & Sons, vol. 39(10), pages 2295-2315, October.
- Nilabja Guha & Anindya Roy & Leonid Kopylev & John Fox & Maria Spassova & Paul White, 2013. "Nonparametric Bayesian Methods for Benchmark Dose Estimation," Risk Analysis, John Wiley & Sons, vol. 33(9), pages 1608-1619, September.
- Daniel Krewski & Robert Smythe & Karen Y. Fung, 2002. "Optimal Designs for Estimating the Effective Dose in Developmental Toxicity Experiments," Risk Analysis, John Wiley & Sons, vol. 22(6), pages 1195-1205, December.
- Christel Faes & Marc Aerts & Helena Geys & Geert Molenberghs, 2007. "Model Averaging Using Fractional Polynomials to Estimate a Safe Level of Exposure," Risk Analysis, John Wiley & Sons, vol. 27(1), pages 111-123, February.
- Daniel O. Scharfstein & Paige L. Williams, 1994. "Design of Developmental Toxicity Studies for Assessing Joint Effects of Dose and Duration," Risk Analysis, John Wiley & Sons, vol. 14(6), pages 1057-1071, December.
- J. Michael Davis & Annie M. Jarabek & David T. Mage & Judith A. Graham, 1998. "The EPA Health Risk Assessment of Methylcyclopentadienyl Manganese Tricarbonyl (MMT)," Risk Analysis, John Wiley & Sons, vol. 18(1), pages 57-70, February.
- Edsel A. Peña & Wensong Wu & Walter Piegorsch & Ronald W. West & LingLing An, 2017. "Model Selection and Estimation with Quantal‐Response Data in Benchmark Risk Assessment," Risk Analysis, John Wiley & Sons, vol. 37(4), pages 716-732, April.
- Matthew W. Wheeler & Todd Blessinger & Kan Shao & Bruce C. Allen & Louis Olszyk & J. Allen Davis & Jeffrey S Gift, 2020. "Quantitative Risk Assessment: Developing a Bayesian Approach to Dichotomous Dose–Response Uncertainty," Risk Analysis, John Wiley & Sons, vol. 40(9), pages 1706-1722, September.
- Jeffrey C. Swartout & Paul S. Price & Michael L. Dourson & Heather L. Carlson‐Lynch & Russell E. Keenan, 1998. "A Probabilistic Framework for the Reference Dose (Probabilistic RfD)," Risk Analysis, John Wiley & Sons, vol. 18(3), pages 271-282, June.
- David W. Gaylor & William Slikker, 1994. "Modeling for Risk Assessment of Neurotoxic Effects," Risk Analysis, John Wiley & Sons, vol. 14(3), pages 333-338, June.
- Brian G. Leroux & Wendy M. Leisenring & Suresh H. Moolgavkar & Elaine M. Faustman, 1996. "A Biologically‐Based Dose—Response Model for Developmental Toxicology," Risk Analysis, John Wiley & Sons, vol. 16(4), pages 449-458, August.
- Raimo I. Niemelä & Jorma Rantanen & Mirja K. Kiilunen, 1998. "Target Levels—Tools for Prevention," Risk Analysis, John Wiley & Sons, vol. 18(6), pages 679-688, December.
- Sushil B. Tamrakar & Anne Haluska & Charles N. Haas & Timothy A. Bartrand, 2011. "Dose‐Response Model of Coxiella burnetii (Q Fever)," Risk Analysis, John Wiley & Sons, vol. 31(1), pages 120-128, January.
- Matthew Wheeler & A. John Bailer, 2012. "Monotonic Bayesian Semiparametric Benchmark Dose Analysis," Risk Analysis, John Wiley & Sons, vol. 32(7), pages 1207-1218, July.
- Marc Aerts & Matthew W. Wheeler & José Cortiñas Abrahantes, 2020. "An extended and unified modeling framework for benchmark dose estimation for both continuous and binary data," Environmetrics, John Wiley & Sons, Ltd., vol. 31(7), November.
- Kaatje Bollaerts & Marc Aerts & Christel Faes & Koen Grijspeerdt & Jeroen Dewulf & Koen Mintiens, 2008. "Human Salmonellosis: Estimation of Dose‐Illness from Outbreak Data," Risk Analysis, John Wiley & Sons, vol. 28(2), pages 427-440, April.
- David Pennington & Pierre Crettaz & Annick Tauxe & Lorenz Rhomberg & Kevin Brand & Olivier Jolliet, 2002. "Assessing Human Health Response in Life Cycle Assessment Using ED10s and DALYs: Part 2—Noncancer Effects," Risk Analysis, John Wiley & Sons, vol. 22(5), pages 947-963, October.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:riskan:v:37:y:2017:i:9:p:1716-1728. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1111/(ISSN)1539-6924 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.